The Meeker-Heaphy Lab

  • Utilizing a combination of tissue-based, cell-based, and molecular approaches, our research goals focus on abnormal telomere biology as it relates to cancer initiation and tumor progression, with a particular interest in the Alternative Lengthening of Telomeres (ALT) phenotype. In addition, our laboratories focus on cancer biomarker discovery and validation with the ultimate aim to utilize these novel tissue-based biomarkers to improve individualized prevention, detection, and treatment strategies.

    Research Areas: preventing cancer metastasis, cancer, tumor cell metastasis

    Lab Website

    Principal Investigator

    Christopher Heaphy, Ph.D.